2. Rübben H, Lutzeyer W, Fischer N, Deutz F, Lagrange W, Giani G. Natural history and treatment of low and high risk superficial bladder tumors. J Urol 1988;139:283–285.
3. Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, et al. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2020;18:329–354.
4. Schmidt S, Francés A, Lorente Garin JA, Juanpere N, Lloreta Trull J, Bonfill X, et al. Quality of life in patients with non-muscle-invasive bladder cancer: one-year results of a multicenter. Urol Oncol 2015;33:19.e7–e19.e15.
5. Yoshimura K, Utsunomiya N, Ichioka K, Matsui Y, Terai A, Arai Y. Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey. Urology 2005;65:290–294.
6. Pham H, Torres H, Sharma P. Mental health implications in bladder cancer patients: a review. Urol Oncol 2019;37:97–107.
7. de Lima MM Jr, Tobias-Machado M. Suicide in patients with genitourinary malignancies. Eur J Cancer Care (Engl) 2017;26.
9. Chan CM, Wan Ahmad WA, Yusof MM, Ho GF, Krupat E. Effects of depression and anxiety on mortality in a mixed cancer group: a longitudinal approach using standardised diagnostic interviews. Psychooncology 2015;24:718–725.
10. Jazzar U, Yong S, Klaassen Z, Huo J, Hughes BD, Esparza E, et al. Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States. Cancer 2018;124:3127–3135.
15. Zhuo M. Neural mechanisms underlying anxiety-chronic pain interactions. Trends Neurosci 2016;39:136–145.
16. Gariépy G, Honkaniemi H, Quesnel-Vallée A. Social support and protection from depression: systematic review of current findings in Western countries. Br J Psychiatry 2016;209:284–293.
17. Zimmermann M, Chong AK, Vechiu C, Papa A. Modifiable risk and protective factors for anxiety disorders among adults: a systematic review. Psychiatry Res 2020;285:112705
18. Lacerda MS, Cirelli MA, Barros AL, Lopes JL. Anxiety, stress and depression in family members of patients with heart failure. Rev Esc Enferm USP 2017;51:e03211.
19. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–370.
20. Li Q, Lin Y, Hu C, Xu Y, Zhou H, Yang L, et al. The Chinese version of hospital anxiety and depression scale: psychometric properties in Chinese cancer patients and their family caregivers. Eur J Oncol Nurs 2016;25:16–23.
21. Vodermaier A, Millman RD. Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer 2011;19:1899–1908.
22. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69–77.
23. Zhang Z, Yang L, Xie D, Wang Y, Bi L, Zhang T, et al. Illness perceptions are a potential predictor of psychological distress in patients with non-muscle-invasive bladder cancer: a 12-month prospective, longitudinal, observational study. Psychol Health Med 2020;25:969–979.
24. Nunes SO, Reiche EM, Morimoto HK, Matsuo T, Itano EN, Xavier EC, et al. Immune and hormonal activity in adults suffering from depression. Braz J Med Biol Res 2002;35:581–587.
25. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001;15:199–226.
26. Leonard BE, Song C. Stress and the immune system in the etiology of anxiety and depression. Pharmacol Biochem Behav 1996;54:299–303.
27. Anda RF, Williamson DF, Escobedo LG, Mast EE, Giovino GA, Remington PL. Depression and the dynamics of smoking. A national perspective. JAMA 1990;264:1541–1545.
28. Sanhueza C, Ryan L, Foxcroft DR. Diet and the risk of unipolar depression in adults: systematic review of cohort studies. J Hum Nutr Diet 2013;26:56–70.
29. Milaneschi Y, Hoogendijk W, Lips P, Heijboer AC, Schoevers R, van Hemert AM, et al. The association between low vitamin D and depressive disorders. Mol Psychiatry 2014;19:444–451.
30. Penninx BW, van Tilburg T, Boeke AJ, Deeg DJ, Kriegsman DM, van Eijk JT. Effects of social support and personal coping resources on depressive symptoms: different for various chronic diseases? Health Psychol 1998;17:551–558.
31. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101–2107.
32. Schneider AK, Chevalier MF, Derré L. The multifaceted immune regulation of bladder cancer. Nat Rev Urol 2019;16:613–630.
33. Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, et al. Bladder cancer. Nat Rev Dis Primers 2017;3:17022
35. Lovejoy NC, Tabor D, Matteis M, Lillis P. Cancer-related depression: Part I--neurologic alterations and cognitive-behavioral therapy. Oncol Nurs Forum 2000;27:667–678.
36. Ostuzzi G, Matcham F, Dauchy S, Barbui C, Hotopf M. Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev 2018;4:CD011006